David J. Benjamin/X
Nov 26, 2024, 11:36
David J. Benjamin: The role of maintenance Avelumab in advanced Urothelial Carcinoma
David J. Benjamin, Medical Oncologist at the Hoag Family Cancer Institute, reshared a post by DAVA Oncology on X:
“Thank you Dr. Jain and DAVA Oncology for the opportunity to discuss the role of maintenance avelumab in advanced urothelial carcinoma.
Identifying patient preferences (balancing survival and quality of life) may help in pairing the right individual with the right regimen.”
Quoting DAVA Oncology‘s post:
“Starting Now:
Checkpoint Inhibitors in Urothelial Carcinoma Moderated by: Tian Zhang.”
For more Updates, Follow OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 1, 2025, 09:02
Mar 1, 2025, 08:56
Mar 1, 2025, 08:45
Mar 1, 2025, 08:32
Mar 1, 2025, 08:26
Feb 28, 2025, 18:34
Feb 28, 2025, 15:34
Feb 28, 2025, 15:33
Feb 28, 2025, 15:25
Feb 28, 2025, 15:22